ANTIBODY/FC RECEPTOR INTERACTIONS IN AIDS MACAQUE MODELS
ANTIBODY/FC RECEPTOR INTERACTIONS IN AIDS MACAQUE MODELS
批准号:
7678015
负责人:
ROBERTA ATTANASIO
金额:
$21.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31
关键词:
AIDS VaccinesAIDS vaccine developmentAcquired Immunodeficiency SyndromeAffectAnimal ModelAntibodiesAntibody FormationAntigensB-LymphocytesBindingBiomedical ResearchCD16 AntigensCD32 AntigensCell LineCercocebusDevelopmentDiseaseEffector CellExhibitsFCGR3B geneFc ReceptorGenesHIV AntigensHIV InfectionsHaptensHela CellsHumanIgG1IgG2IgG3IgG4Immune responseImmunoglobulin AImmunoglobulin Constant RegionImmunoglobulin GImmunoglobulin Variable RegionIn VitroInfectionKnowledgeLeadLengthMacacaMacaca mulattaMediatingModelingMonoclonal AntibodiesPassive ImmunizationPathogenesisPlayProductionPropertyReceptor GeneRecombinant AntibodyRecombinantsResearchRoleSIVSystemSystems AnalysisTestingVaccinesViralbasecell typedesigngenome sequencingimprovedin vivoinsightneutralizing antibodynonhuman primatepathogenprotective efficacypublic health prioritiespublic health relevancereceptorresearch studytoolvaccine developmentvaccine efficacy
中文摘要
描述(由申请人提供):恒河猴是艾滋病研究和疫苗开发的主要工具。最近恒河猴基因组序列和猕猴特异性基因的微阵列芯片的可用性无疑增加了恒河猴在生物医学研究中的潜力。然而,尽管有这些重大的改进,需要做很多工作,以完成这一模式的特性。被动免疫实验以及通过消耗SIV感染的恒河猴中的B细胞进行的实验的最新发现证实,抗体应答代表对抗由SIV引起的感染和疾病的主要保护组分之一。抗体通过其可变区与特异性抗原结合,然后通过其恒定区激活效应器机制来消除病原体。效应器机制的激活通过恒定区与多种细胞类型上表达的Fc受体结合而发生。各种抗体/Fc受体系统和相关的病原体清除机制在非人灵长类动物模型中仍然很大程度上未被表征。因此,本申请的目的是鉴定恒河猴Fc受体并定义由这些受体介导的抗体功能特性。为了实现我们的目标,我们将鉴定Fc受体基因,在细胞系中表达这些受体的重组形式,用于使用重组恒河猴抗体分子研究抗体/受体相互作用,并评估恒河猴IgG和伊加分子触发特异性效应子功能的能力。从拟议的研究结果将提供必要的信息,以准确地评估艾滋病猕猴模型的抗体反应的幅度和保护效力。公共卫生相关性:开发艾滋病疫苗是公共卫生的优先事项。虽然这种疫苗的开发需要使用恒河猴模型,但这种模型仍然没有特征。由于抗体反应是众所周知的,发挥了重要作用,在保护免受艾滋病毒感染,我们建议的特点抗体/Fc受体的相互作用和由此产生的病原体清除机制在恒河猴。这些研究结果将为恒河猴模型在艾滋病疫苗开发中的最佳利用提供所需的信息。
英文摘要
DESCRIPTION (provided by applicant): The rhesus macaque represents a major tool for AIDS research and vaccine development. The recent availability of the rhesus macaque genome sequence and microarray chips of macaque-specific genes has certainly increased the potential of the rhesus macaque in biomedical research. However, despite these major improvements, much needs to be done to complete the characterization of this model. Recent findings from passive immunization experiments as well as from experiments performed by depleting B cells in SIV-infected rhesus macaques confirm that antibody responses represent one of the major protective components against infection and disease caused by SIV. Antibodies eliminate pathogens by binding specific antigens with their variable regions and then by activating effector mechanisms through their constant regions. The activation of effector mechanisms occurs through the binding of the constant regions to Fc receptors expressed on a variety of cell types. The various antibody/Fc receptor systems and related pathogen-clearance mechanisms are still largely uncharacterized in nonhuman primate models. Therefore, the objective of this application is the identification of rhesus macaque Fc receptors and the definition of the antibody functional properties that are mediated by these receptors. To accomplish our objective, we will identify Fc receptor genes, express recombinant forms of these receptors in cell lines for the study of antibody/receptor interactions using recombinant rhesus macaque antibody molecules, and assess the ability of rhesus macaque IgG and IgA molecules to trigger specific effector functions. Results from the proposed studies will provide necessary information to accurately assess magnitude and protective efficacy of antibody responses in AIDS macaque models. PUBLIC HEALTH RELEVANCE: The development of an AIDS vaccine represents a public health priority. Although development of such a vaccine requires the use of rhesus macaque models, such models are still uncharacterized. Because antibody responses are known to play a major role in protecting from HIV infection, we propose to characterize antibody/Fc receptor interactions and resulting pathogen clearance mechanisms in rhesus macaques. Results form these studies will provide needed information for the optimal utilization of rhesus macaque models in developing AIDS vaccines.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
ANTIBODY/FC RECEPTOR INTERACTIONS IN AIDS MACAQUE MODELS
-
批准号:7554817
-
项目类别:
-
资助金额:$18.06万
-
财政年份:2008
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES - DEFINITION OF HUMORAL IMMUNITY
-
批准号:7165381
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2005
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES--DEFINITION OF HUMORAL IMMUNITY
-
批准号:6394639
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
DEFINITION OF HUMORAL IMMUNITY
-
批准号:2703185
-
项目类别:
-
资助金额:$6.53万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES--DEFINITION OF HUMORAL IMMUNITY
-
批准号:2765555
-
项目类别:
-
资助金额:$9.7万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES--DEFINITION OF HUMORAL IMMUNITY
-
批准号:2333148
-
项目类别:
-
资助金额:$3.47万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES--DEFINITION OF HUMORAL IMMUNITY
-
批准号:6188399
-
项目类别:
-
资助金额:$10.16万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
AUTOANTIBODY RESPONSES ASSOCIATED W/ SIV INFECTION
-
批准号:6247326
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
NIH MACAQUE RESOURCES--DEFINITION OF HUMORAL IMMUNITY
-
批准号:2910785
-
项目类别:
-
资助金额:$10.23万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
IMMUNOGENICITY OF MYCOBACTERIUM TB CULTURE FILTRATE PROTEINS IN RHESUS:VACCINE
-
批准号:6247327
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1997
-
负责人:ROBERTA ATTANASIO
-
依托单位:
DEFINITION OF HUMORAL IMMUNITY
-
批准号:2286326
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:ROBERTA ATTANASIO
-
依托单位:
REGULATION OF B CELL IMMUNE RESPONSES--SIV INFECTED RHESUS MONKEYS
-
批准号:5219861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERTA ATTANASIO
-
依托单位:--
IDIOTYPE MAPPING OF MONOCLONAL ANTI CD4 ANTIBODIES USING SYNTHETIC PEPTIDES
-
批准号:3869595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERTA ATTANASIO
-
依托单位:
海外基金